Multiplatform molecular profiling of male breast cancer (MBC) reveals significant differences in actionable targets from matched female breast carcinomas | Caris Life Sciences
Home / Research / Publications / Multiplatform molecular profiling of male breast cancer (MBC) reveals significant differences in actionable targets from matched female breast carcinomas

Publications

Multiplatform molecular profiling of male breast cancer (MBC) reveals significant differences in actionable targets from matched female breast carcinomas

Introduction

Male breast cancer (MBC) is rare, occurring in ~1% of all breast cancers. While clinically characterized as being similar to postmenopausal ER+ BC, MBC has been much less characterized molecularly than female BC.

Download Publication
Learn More
Name(Required)